Navigation Links
Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1
Date:11/27/2011

pleased to have enrolled the first patient in this pivotal clinical study."

Inspiration in-licensed OBI-1 from Ipsen as part of their January 2010 partnership agreement, whereby Inspiration is responsible for the clinical development, regulatory approval and commercialization of the product.  Previously, in November 2010, Inspiration initiated the first pivotal study of OBI-1 for the treatment of individuals with acquired hemophilia A, a rare, potentially life-threatening autoimmune bleeding disorder caused by the development of inhibitors against endogenous FVIII.  Results from the first patients in this clinical study were presented in a Scientific Session held in conjunction with the 23rd Congress of the International Society on Thrombosis and Haemostasis (ISTH) in July 2011.  Enrollment in the OBI-1 acquired hemophilia clinical trial is ongoing.

John P. Butler, Chief Executive Officer of Inspiration, commented, "Inspiration is committed exclusively to driving innovation that can bring positive impact to the treatment of people with hemophilia.  We now have OBI-1 in pivotal development for multiple indications.  We also recently announced the filing of a Marketing Authorization Application (MAA) for our other lead program, IB1001, a recombinant factor IX product for the treatment of hemophilia B.  These two late stage products, along with our preclinical programs for factor VIIa and FVIII deficiency, gives Inspiration one of the broadest pipelines for hemophilia treatment in the industry.  As a company, we are committed to developing and commercializing an array of hemophilia products, which will provide value to physicians and to people living with the condition worldwide."

About HemophiliaHemophilia is a bleeding disorder caused by low levels or the absence of a protein called a coagulation factor, essential for blood clotting.  The two most common forms of hemophilia are types A and B.  Hemop
'/>"/>

SOURCE Inspiration Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
2. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
3. Inspiration for My Sisters Keeper Speaks Out
4. National Expressions of Courage Art Contest Unveils Stories of Inspiration
5. Inspiration Biopharmaceuticals OBI-1 Receives Orphan Drug Designation in Europe
6. Inspiration Biopharmaceuticals Awarded Two Grants Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP)
7. Siemens MAMMOMAT Inspiration Digital Mammography Commercially Available in U.S.
8. Inspiration Biopharmaceuticals Treats First Patient in Pivotal Study of OBI-1 for Acquired Hemophilia A
9. Inspiration Biopharmaceuticals Demonstrates Non-Inferiority of IB1001, Its Recombinant Factor IX for Hemophilia B
10. Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress
11. Heskas 2011 "Inspiration in Action" Contest Begins: Support the Veterinary Profession and Help Animals in Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 As of February, InControl ... devices for women. "Shipping thousands of ... part is the hundreds of letters, emails and ... have been positively impacted by our technology," said ... InControl recently released Apex, an over-the-counter solution ...
(Date:3/27/2015)... , March 27, 2015 ... 2015" therapeutic market research report of 52 pages ... online business intelligence library. The report ... on the therapeutic development for Visceral Pain, complete ... by drug target, mechanism of action (MoA), route ...
(Date:3/26/2015)... WOODBRIDGE, ON , March 26, 2015 /PRNewswire/ - Pivotal ... specialty pharmaceutical company with a focus on Omega-3 therapies ... March 25, 2015 it issued 763,752 common shares of ... payment of interest for the period of December 5 ... on its outstanding Convertible Notes that is due on ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... 2011 RESMED INC. (NYSE: RMD ), announced ... its results for the third quarter and nine months of ... with ResMed,s results will be issued after 1:00 p.m. Pacific ... webcast to review its results, market trends, and future outlook. ...
... 2011 CVS Caremark has been named as ... United States, according to the 2011 Most Reputable ... partnership with the Reputation Institute. (Logo: ... in the survey, CVS Caremark ranked 30th. Survey ...
Cached Medicine Technology:ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2011 Results 2CVS Caremark Named One of America's Most Reputable Companies by Reputation Institute 2
(Date:3/29/2015)... 2015 At this initial launch, ... basic health information around medical conditions that individuals ... challenges as well as helping them find solutions ... medical conditions using evidenced based information in print ... conversations around them., ,     Diabetes, ...
(Date:3/28/2015)... WA (PRWEB) March 28, 2015 Rocket ... athletes, recently announced the release of their new natural sunscreen. ... and 3 ounce packages. Both options come with a ... purchased at RocketPure.com or on Amazon. Click to ... description states that the natural sunscreen is made with non-nano ...
(Date:3/28/2015)... With more than 4,500 scientists, ... osteoporosis, osteoarthritis and musculoskeletal diseases gathered here for ... the first time in the 17-year history of ... hot-button topic is an emerging non-pharmaceutical protocol for ... principles of Wolff’s law, osteogenic loading at multiples ...
(Date:3/28/2015)... York, NY (PRWEB) March 28, 2015 ... highlighted a problem which could prove critical to organizations ... system testing, a critical aspect of data security, is ... card industry data security report, every major category out ... scanning and penetration testing. “With all the craziness that ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
Breaking Medicine News(10 mins):Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2
... 20-Year Specialist Recognized for Its Achievements, CARROLLTON, ... the precision construction of medical imaging facilities, has,been ... the November issue of,Construction Digital magazine. The feature, ... at the company, its leadership and the,story behind ...
... Contentious Audit ... Compliance, MILWAUKEE, Dec. 5 InvoiceCHECK, an innovative ... for each,invoice, has been introduced by TRICAST., InvoiceCHECK ... company receives an invoice for its prescription benefit,claims., ...
... Its Offerings by Adding Dental to Medical Benefits, ... nationwide health,benefits provider that offers uninsured or partially ... today announced the,formation of its latest partnership with ... the nation,s largest independent dental PPO networks,with more ...
... Calif., Dec. 5 BioForm Medical,Inc. (Nasdaq: BFRM ... will,report its September 30, 2007 first quarter fiscal year ... release after the NASDAQ,Global Market closes and will hold ... (5:30 p.m. Eastern Time)., BioForm Chief Executive Officer ...
... partners,from the 16th annual Halloween Promotion benefiting St. ... of the projected $4.8,million donation to the hospital ... Companies represented at the check presentation included,A&P Family ... Fox,& Hound, Hess Corporation, Petro Stopping Centers, Saladworks ...
... who believe,in themselves can raise their aspirations, motivation and ... watching others do them., So says Albert Bandura, ... has won the 2008 University of Louisville,Grawemeyer Award for ... from among 31 nominations from five countries., Bandura,s ...
Cached Medicine News:Health News:Fry Construction Is Featured in Key Industry Publication 2Health News:'InvoiceCHECK' Cuts Prescription Benefit Waste 2Health News:DenteMax Forms Business Alliance With MEDILINQ 2Health News:BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 2007 2Health News:National Partners from St. Jude Halloween Promotion Presents More Than $1.7 Million to Help Fight Childhood Cancer 2Health News:Self-Confidence Can Make Us Better, Says Grawemeyer Psychology Winner 2
... surgery and other types of refractive surgery. ... stromal bed. Flattened tip provides easy insertion ... flap edge. Multiple ports provide multi-directional irrigation. ... 7mm from end. Two .15mm ports 2mm, ...
... designed for LASIK surgery and other ... irrigate the corneal interface and/or stromal ... under the flap and helps elevate ... multi-directional irrigation. 21G x 7/8in (.80 ...
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 23G x 7/8 in (.60 x 22mm). .3mm end port. Olive shape tip is 2mm long x 1mm w...
For injecting anesthetics into the muscle cone. 25G x 1 1/2 in (.50 x 38mm)...
Medicine Products: